1. Home
  2. CSTL vs FBIZ Comparison

CSTL vs FBIZ Comparison

Compare CSTL & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • FBIZ
  • Stock Information
  • Founded
  • CSTL 2007
  • FBIZ 1909
  • Country
  • CSTL United States
  • FBIZ United States
  • Employees
  • CSTL N/A
  • FBIZ N/A
  • Industry
  • CSTL Medical Specialities
  • FBIZ Major Banks
  • Sector
  • CSTL Health Care
  • FBIZ Finance
  • Exchange
  • CSTL Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • CSTL 471.5M
  • FBIZ 390.3M
  • IPO Year
  • CSTL 2019
  • FBIZ N/A
  • Fundamental
  • Price
  • CSTL $19.36
  • FBIZ $47.24
  • Analyst Decision
  • CSTL Strong Buy
  • FBIZ Strong Buy
  • Analyst Count
  • CSTL 6
  • FBIZ 4
  • Target Price
  • CSTL $37.67
  • FBIZ $56.50
  • AVG Volume (30 Days)
  • CSTL 554.7K
  • FBIZ 41.2K
  • Earning Date
  • CSTL 08-04-2025
  • FBIZ 07-24-2025
  • Dividend Yield
  • CSTL N/A
  • FBIZ 2.48%
  • EPS Growth
  • CSTL N/A
  • FBIZ 22.50
  • EPS
  • CSTL N/A
  • FBIZ 5.60
  • Revenue
  • CSTL $346,269,000.00
  • FBIZ $150,952,000.00
  • Revenue This Year
  • CSTL N/A
  • FBIZ $17.98
  • Revenue Next Year
  • CSTL $1.62
  • FBIZ $8.26
  • P/E Ratio
  • CSTL N/A
  • FBIZ $8.44
  • Revenue Growth
  • CSTL 20.40
  • FBIZ 8.24
  • 52 Week Low
  • CSTL $14.59
  • FBIZ $39.65
  • 52 Week High
  • CSTL $35.84
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 58.66
  • FBIZ 35.18
  • Support Level
  • CSTL $18.81
  • FBIZ $46.55
  • Resistance Level
  • CSTL $21.33
  • FBIZ $48.25
  • Average True Range (ATR)
  • CSTL 0.92
  • FBIZ 1.31
  • MACD
  • CSTL 0.45
  • FBIZ -0.45
  • Stochastic Oscillator
  • CSTL 70.74
  • FBIZ 15.60

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: